Lazard Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.66M Buy
103,011
+54,768
+114% +$3.86M 0.01% 494
2025
Q4
$3.25M Sell
48,243
-22,755
-32% -$1.53M 0.01% 690
2025
Q3
$5.21M Buy
70,998
+35,226
+98% +$2.34M 0.01% 570
2025
Q2
$1.86M Sell
35,772
-54,119
-60% -$3.08M ﹤0.01% 1035
2025
Q1
$5.73M Buy
89,891
+18,197
+25% +$1.06M 0.01% 641
2024
Q4
$3.43M Sell
71,694
-145,961
-67% -$7.48M 0.01% 726
2024
Q3
$12.5M Sell
217,655
-234,901
-52% -$13.5M 0.02% 423
2024
Q2
$23.7M Sell
452,556
-353,419
-44% -$15.5M 0.03% 342
2024
Q1
$32.8M Sell
805,975
-91,372
-10% -$3.43M 0.04% 290
2023
Q4
$33.2M Buy
897,347
+36,873
+4% +$1.39M 0.04% 287
2023
Q3
$32.9M Sell
860,474
-338,193
-28% -$13.9M 0.04% 275
2023
Q2
$43.2M Buy
1,198,667
+499,063
+71% +$17M 0.05% 234
2023
Q1
$26.7M Buy
699,604
+254,063
+57% +$11.9M 0.04% 344
2022
Q4
$25.4M Sell
445,541
-41,902
-9% -$2.15M 0.03% 359
2022
Q3
$19.3M Buy
487,443
+481,440
+8,020% +$21.3M 0.03% 421
2022
Q2
$264K Buy
6,003
+5,810
+3,010% +$251K ﹤0.01% 1222
2022
Q1
$7K Sell
193
-2,984
-94% -$106K ﹤0.01% 2162
2021
Q4
$127K Buy
3,177
+639
+25% +$23.9K ﹤0.01% 1374
2021
Q3
$103K Sell
2,538
-162
-6% -$6.77K ﹤0.01% 1411
2021
Q2
$122K Buy
2,700
+198
+8% +$8.76K ﹤0.01% 1298
2021
Q1
$104K Buy
2,502
+480
+24% +$21.9K ﹤0.01% 1198
2020
Q4
$86K Hold
2,022
﹤0.01% 1218
2020
Q3
$53K Sell
2,022
-148,718
-99% -$4.14M ﹤0.01% 1171
2020
Q2
$4.04M Buy
+150,740
New +$3.4M 0.01% 599
2020
Q1
Sell
-2,522
Closed -$44K 1638
2019
Q4
$44K Buy
2,522
+2,058
+444% +$35.6K ﹤0.01% 1085
2019
Q3
$7K Buy
+464
New +$7.64K ﹤0.01% 1336

Other funds holding HALO

Lazard Asset Management's HALO Position: Q1 2026 in Review

Lazard Asset Management increased its Halozyme (HALO) stake by 114% in Q1 2026, buying an estimated $3.86M and bringing the position to 103,011 shares worth $6.66M. The position accounts for 0.01% of the portfolio, ranked #494.

Lazard Asset Management first reported a position in HALO in Q3 2019 and has held it in 26 quarters since. The position peaked at $43.2M in Q2 2023. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Lazard Asset Management held 103,011 shares of Halozyme worth $6.66M as of Q1 2026.
  • Lazard Asset Management bought 54,768 Halozyme shares in Q1 2026, an estimated $3.86M.
  • Halozyme made up 0.01% of Lazard Asset Management's portfolio in Q1 2026, its #494 holding.
  • Lazard Asset Management first reported a position in Halozyme in Q3 2019 and has held it in 26 quarters since.
  • Lazard Asset Management's Halozyme position peaked at $43.2M in Q2 2023.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.